Latest updates for Claruvis Pharmaceutical
Fresh curated links around Claruvis Pharmaceutical are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine
- <![CDATA[Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu]]>
- <![CDATA[Angelini Pharma Enters $ 4.1 Billion Agreement to Acquire Catalyst Pharmaceuticals ]]>
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
<![CDATA[Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu]]>
<![CDATA[Angelini Pharma Enters $ 4.1 Billion Agreement to Acquire Catalyst Pharmaceuticals ]]>
<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics]]>
<![CDATA[Pharmaceutical Executive Daily: FDA Issues CRL to AbbVie]]>
<![CDATA[Pharmaceutical Executive Daily: Angelini Pharma Acquires Catalyst Pharmaceuticals in $4.1 Billion Agreement]...
<![CDATA[UCB Enters $2.2 Billion Agreement to Acquire Candid Therapeutics ]]>
Cellectar (CLRB) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DateThursday, May 14, 2026 at 8:30 a.m. ETCall participantsPresident and CEO — James CarusoChief Financial Officer — Chad KoleanChief Operating Offi...
<![CDATA[Pharmaceutical Executive Daily: AbbVie and Haisco Enter $745 Million Licensing Agreement]]>
<![CDATA[Teva Enters $900 Million Agreement to Acquire Emalex]]>
Millicent Pharma/Eversana
Millicent Pharma/Eversana Anonymous (not verified) Sun, 05/03/2026 - 14:19 field_thread_url https://cafepharma.com/boards/threads/millicent-pharma-eversana...
<![CDATA[Haisco Enters $745 Million Exclusive License Agreement with AbbVie ]]>
<![CDATA[Eli Lilly Enters $7 Billion Agreement to Acquire Kelonia Therapeutics ]]>
BioDelivery Sciences Int’l, Inc. v. Alvogen PB Research & Development LLC
This case was filed in 2018 when Alvogen submitted to the FDA an ANDA for approval to market generic Belbuca, a buprenorphine buccal film used to administer the drug transmucosally...
<![CDATA[Travere Therapeutics’ Filspari Receives Full FDA Approval ]]>
<![CDATA[Pharmaceutical Executive Daily: UCB to Acquire Candid Therapeutics]]>
<![CDATA[Obsidian Therapeutics and Galera Therapeutics Enter $350 Million Merger Agreement]]>
<![CDATA[Pharmaceutical Executive Daily: Neurocrine Biosciences Agrees to Acquire Soleno Therapeutics]]>
Tolmar Pharmaceuticals
Tolmar Pharmaceuticals Anonymous (not verified) Sat, 04/11/2026 - 05:03 field_thread_url https://cafepharma.com/boards/threads/tolmar-pharmaceuticals.56651...
Bausch, MSN Laboratories Settle Patent Battle Over IBS Drug
Bausch Health and MSN Laboratories have ended their New Jersey patent fight over the irritable bowel medication Trulance after reaching a confidential settlement, filing a stipulat...
<![CDATA[Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement ]]>
Revolution Medicines
Revolution Medicines Anonymous (not verified) Tue, 05/05/2026 - 02:20 field_thread_url https://cafepharma.com/boards/threads/revolution-medicines.709803/...
The FDA Cracks Down on Tavneos
The FDA Cracks Down on Tavneos Anonymous (not verified) Thu, 04/30/2026 - 14:18 pharmagather item url The FDA Cracks Down on Tavneos pha...
<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio]]>
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.